FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used for assessing the efficiency of simulated lymphocyte membrane lipid peroxidation. That is ensured by pre-processing lymphocytes with hydrogen peroxide in the final concentration of 0.5 mM, and measuring protein-bound glutathione. If the measured protein-bound glutathione increases three times as much or more, the stimulated peroxidation is considered to be effective, while the peroxidation is considered to be ineffective if accompanied by a 2-fold or less increase of the protein-bound glutathione.
EFFECT: invention enables assessing the experimentally simulated lymphocyte membrane lipid peroxidation.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TECHNIQUE FOR LYMPHOCYTE APOPTOSIS | 2013 |
|
RU2545900C2 |
| METHOD FOR PREDICTION OF EARLY STAGE OF APOPTOSIS | 2013 |
|
RU2540500C2 |
| METHOD FOR ESTIMATING EFFECTIVENESS OF ANTIOXIDANT ACTIVITY STIMULATION | 2013 |
|
RU2516925C1 |
| METHOD FOR CELL PROTECTION AGAINST APOPTOSIS | 2013 |
|
RU2541774C2 |
| METHOD FOR ASSESSING EFFECTIVENESS OF LYMPHOCYTE PROTECTION AGAINST APOPTOSIS | 2014 |
|
RU2568886C1 |
| METHOD FOR PREDICTION OF EFFECTIVENESS OF LYMPHOCYTE PROTECTION AGAINST PEROXIDATION | 2013 |
|
RU2525183C1 |
| AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
| ANTIOXIDANT, STRESS- AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT POTASSIUM COMENATE | 2012 |
|
RU2514632C1 |
| ANTIOXIDANT, STRESS AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT SODIUM COMENATE | 2012 |
|
RU2506078C1 |
| METHOD OF GENETIC TYPING OF POLYMORPHISM rs2551715 OF HUMAN GLUTATHIONE REDUCTASE GENE | 2013 |
|
RU2549688C1 |
